ロード中...
The Promises and Pitfalls of Reboxetine
The antidepressant compound, morpholine, 2‐[(2‐ethoxyphenoxy)phenylmethyl]‐, methanesulfonate, or reboxetine, is a selective noradrenergic reuptake inhibitor that acts by binding to the norepinephrine (NE) transporter and blocking reuptake of extracellular NE back into terminals. This compound has l...
保存先:
| 出版年: | CNS Drug Rev |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Blackwell Publishing Ltd
2006
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6741698/ https://ncbi.nlm.nih.gov/pubmed/14647527 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1527-3458.2003.tb00258.x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|